Numerion Labs Patents

Patent portfolio assigned to Numerion Labs (verified via public assignee records). Numerion Labs is the rebrand/successor of Atomwise (YC W15; shared founders incl. Abraham Heifets). AI drug discovery (AtomNet). Patents confirmed under assignee 'Atomwise Inc' (e.g. US9373059B1, EP3680820A1) -- has_patents true on Atomwise lineage; exact current count not displayed. Eli Lilly pharma collaboration confirmed via press; pharma partnerships are attributed to Atomwise, hence medium confidence for the renamed entity.